Summary. The oral and intravenous glucose tolerance tests have been compared in middle-aged, normal-weight male non-smokers, ex-smokers and smokers who participated in a general health screening programme in Malm6, Sweden. Subjects with diabetes, previous gastric resection and/or present medication with diuretic agents were excluded. No difference was found when comparing fasting glucose in non-smokers, ex-smokers and smokers. In the oral glucose tolerance test, plasma glucose at 40 and 60 min increased stepwise from nonsmokers (8.7 and 7.4mmol/1) to ex-smokers (8.9 and 7.5 retool/l), smokers (9.2 and 7.9 mmol/1) and heavy smokers (9.7 and 8.2 mmol/1). Blood glucose levels at 120 min were inversely arranged. Plasma insulin at 120min was lower in heavy smokers (16.2 mU/1) than in non-smokers (24.8 mU/l). The mean intravenous glucose tolerance test k-value was lower in smokers than in non-smokers. K-values below 1.0 were twice as common in smokers (30%) as in non-smokers. It is concluded that smoking has a clinically significant influence on both the oral and intravenous glucose tolerance tests.
The transient increase in blood glucose associated with smoking represents one of the many well known acute effects of nicotine [1] . So far little has been published on chronic effects of smoking on glucose metabolism. Our previous studies on the oral and intravenous glucose tolerance tests in middle-aged heavy smokers and nonsmokers showed that heavy smokers have significantly higher glucose value during the early phase of the oral glucose tolerance test whereas their 2-h value is significantly lower. The comparison of intravenous glucose tolerance test in smokers and non-smokers suggested that smoking is associated with a reduced clearance of glucose from plasma.
In order to explore further these associations, we have now extended our study to include non-smokers, ex-smokers, smokers and heavy smokers. Potential confounding factors have been controlled for by confining the study to middle-aged, non-diabetic, normal weight men without previous gastric resection and/or present medication with diuretic agents.
Material and Methods
From November 1974 consecutive middle-aged male birth cohorts in Malm6 have been invited to take part in a general health screening programme at the Department of Preventive Medicine, Malm6 General Hospital. Details of the programme have been published elsewhere [5] . The participation rate in these cohorts was about 75%. The present study was confined to men born between 1926 and 1929. None had clinical or chemical signs of diabetes (ie fasting blood glucose> 7.0 mmol/1). Subjects with a history of gastric resection and/or present medication with diuretic agents were excluded. Furthermore, the comparison was restricted to men with normal body weight (actual/ideal weight index between 0.95-1.05 as calculated according to Lindeberg et al. [6] .) The mean actual/ideal weight index was 1.0 in all groups studied.
All subjects were instructed to fast and to abstain from tobacco for 10 h before examination. Smoking abstinence was checked by questioning. Participants were randomly allocated to screening by oral and intravenous tolerance test (GTT) procedures. For the oral GTT, data were available on 325 non-smokers, 300 ex-smokers, 681 smokers and 148 heavy smokers. For the IV GTT data were available in 113 non-smokers, 71 ex-smokers, 193 smokers and 52 heavy smokers.
Smoking Habits
Smoking habits were assessed by questionnaire [7] . Categories were defined as follows: (1) non-smokers had never smoked regularly; (2) ex-smokers had smoked at least 1 g of tobacco daily for at least 1 year, but at the time of examination had not smoked for at least I month; (3) smokers smoked daily; (4) heavy smokers smoked at least 20 g of tobacco daily.
One cigarette was considered equal to 1 g of tobacco, 1 cigar to 5 g and one packet of pipe tobacco equal to 50 g.
Oral Glucose Tolerance Test
Glucose (30g/m 2 body area in 10% aqueous solution) was ingested within 10min. Blood glucose was measured at 0, 40, 60, 90 and 120 min by a standard method [8] . Plasma insulin immunoreactivity was determined in triplicate at 0, 40 and 120 min by a radioimmunoassay technique [9] .
Intravenous Glucose Tolerance Test
In the IV GTT, an intravenous catheter for repeated blood sampling was introduced into the left or fight antecuhital fossa and kept open by flushing with saline 0.9% after the sampling procedures. Glucose (25 g/m 2 body surface area in 40% sterile aqueous solution) was in- 
Statistical Methods
Student's t-test was used for comparison of mean blood glucose values in the four groups. The distribution of insulin was not normally distributed. For this reason, insulin values in the different smoking categories were compared using z-square on the r x c contingency table of frequencies within specified groups, p values < 0.05 were considered statistically significant.
Results

Oral Glucose Tolerance Test
Fasting blood glucose values were not signifiantly different in the four groups (Table 1) . At 40 rain, the glucose concentration was higher in the smokers, (particularly the heavy smokers) than in non-smokers or ex-smokers. The same pattern was found at 60 rain.
Mean glucose values at 90min did not differ significantly between groups. At 120 rain, however, smokers had significantly lower values than did non-smokers and ex-smokers.
Fasting insulin values did not differ significantly between groups. At 40 rain, smokers and heavy smokers tended to have higher insulin values than non-smokers, but the difference did not reach statistical significance. At 120 rain, smokers and heavy smokers had lower insulin than non-smokers.
Intravenous Glucose Tolerance Test
As in the oral GTT, fasting values of glucose and insulin did not differ significantly between groups (Table 2) . At 5 rain, blood glucose was lower in smokers than in nonsmokers. Plasma insulin values at 5 min and 60 min and glucose at 60 and 90 rain were not significantly different in the four groups. The glucose disappearance constant (k-value) was significantly lower in smokers (particularly heavy smokers) than in non-smokers or ex-smok-ers. In the present screening, k-values above 1.0 were considered normal. K-values equal to or below 1.0 were observed in 31% of the heavy smokers, but only in 13% of the non-smokers and 15% of the ex-smokers.
Discussion
Several factors are known to have an influence on the oral and intravenous GTT. This study illustrates the significant clinical long term effects associated with smoking. We concluded that smoking habits must be considered when interpreting results from both oral and intravenous glucose tolerance tests.
Invitations to screening were made in a random fashion and the same standardized screening procedure was used for all participants. Hence it is not possible to explain the observed differences between smokers and non-smokers on the basis of seasonal and/or methodological differences. Since all smokers had abstained from tobacco for at least 10h before examination and since the half-life of nicotine is less than 1 h [10], it is reasonable to assume that the observed influence of smoking on the oral and intravenous GTT represented the chronic effects of smoking. The high 40-min blood glucose value in the oral GTT might reflect a more rapid absorption from the intestine in smokers than in nonsmokers. It is less fikely to reflect different dietary habits in these two groups [11] since the 40min value increased stepwise when comparing non-smokers, exsmokers, smokers and heavy smokers. A difference between smokers and ex-smokers at 40, 60 and 120 rain indicated that the effect of smoking on the oral GTT was reversible. Although no difference was found when comparing the 120min value in smokers and heavy smokers, it appears that the effect of smoking on the 120 min value was dose-related since in an earlier study the 2 h value was found to be inversely related to the concentration of carboxyhaemoglobin [12] .
The low k-value in the intravenous GTT in smokers seems incompatible with their low 2 h value in the oral glucose tolerance test. Since the two test procedures were not performed in the same subjects, we cannot assess whether the low 120 min value in the oral GTT in smokers was associated with impaired elimination of glucose from plasma. The impaired plasma clearance associated with smoking was strengthened by the even lower k-value in heavy smokers. However, the intermediate k-value in ex-smokers indicated that this influence of smoking was reversible. The impaired elimination of glucose associated with smoking could have many explanations. Some studies have reported lower plasma volumes in smokers than in non-smokers [13] . Since the given amount of glucose in the intravenous GTT was calculated on the b~isis of body weight and height, this could lead to a higher blood glucose concentration in smokers than in non-smokers. In the present study, however, smokers were found to have significantly lower blood glucose values than non-smokers at 5 min, i.e. at the time when the mixture of glucose and plasma should be complete. One explanation might be the inferred effect of smoking on other hormones. In acute experiments smoking has been found to be associated with increased release of somatotropin [14] , thyroid hormones [15] and catecholamines [16] which are known to counteract the effects of insulin on blood glucose.
